Drug Treatment of Obesity in Type 2 Diabetes Mellitus

Obesity is a common problem in Type 2 diabetes mellitus, and reduction of weight in obese diabetic patients will lead to an improvement in glucose tolerance. Despite the importance of weight loss, obese diabetic patients often fail to lose weight with advice on dietary restriction. Frequent visits to see the dietician provide the best chance of successful weight loss, and should be an important part of the management of the overweight patient. If this line of treatment is unsuccessful, then drug therapy may be considered to assist the patient in adhering to the dietary restriction. Over the past decade, drug therapy for weight loss has fallen into disrepute in the wake of the abuse of amphetamines and thyroid hormones by both patients and doctors. For this reason, the only drug commonly used in the diabetic clinic to assist patients to lose weight is metformin because of its putative therapeutic effect on obesity. However, currently available anorectic agents have much less potential for abuse by patients than their predecessors, and new drugs are being developed in this field.

[1]  L. Mcalpine,et al.  A comparison of treatment with metformin and gliclazide in patients with non-insulin-dependent diabetes , 2004, European Journal of Clinical Pharmacology.

[2]  G. Gill,et al.  Factors affecting weight loss in obese Type 2 diabetes — the vital role of the dietitian , 1989 .

[3]  R. Jung,et al.  Weight loss in obese subjects on a restricted diet given BRL 26830A, a new atypical β adrenoceptor agonist , 1988, British medical journal.

[4]  Chapman Bj,et al.  The effects of a new beta-adrenoceptor agonist BRL 26830A in refractory obesity. , 1988 .

[5]  V. Piercy,et al.  Treatment of obesity with thermogenic beta-adrenoceptor agonists: studies on BRL 26830A in rodents. , 1984, International journal of obesity.

[6]  S. Thenen,et al.  Influence of diet on de novo lipogenesis in artificially-fed 15- and 20-day-old Zucker fatty rats. , 1984, International journal of obesity.

[7]  T. Silverstone.  Psychopharmacology of hunger and food intake in humans. , 1982, Pharmacology & therapeutics.

[8]  D. Borsey,et al.  The treatment and progress of obese insulin independent diabetics. , 1979, The Practitioner.

[9]  J. Wales.  The effect of fenfluramine on obese, maturity-onset diabetic patients. , 1979, Acta endocrinologica.

[10]  M. Thompson,et al.  The influence of fenfluramine on oral glucose tolerance tests, plasma sugar and insulin levels in newly diagnosed late-onset diabetic patients , 1979 .

[11]  B. Clarke,et al.  Comparison of metformin and chlorpropamide in non-obese, maturity-onset diabetics uncontrolled by diet. , 1977, British medical journal.

[12]  J. Innes,et al.  Plasma fenfluramine levels, weight loss, and side effects. , 1977, British medical journal.

[13]  Bhalla Ip,et al.  A controlled trial of phentermine in obese diabetic patients. , 1977 .

[14]  Shearer Rs.  Effects of bulk-producing tablets on hunger intensity in dieting patients. , 1976 .

[15]  Bandisode Ms,et al.  Double-blind clinical evaluation of mazindol (42-548) in obese diabetics. , 1975 .

[16]  Barbara S. Van Yserloo,et al.  Relationship of ovesity and disease in 73,532 weight-conscious women. , 1975, Public health reports.

[17]  D. Campbell,et al.  The anorectic activity of fenfluramine. , 1975, Postgraduate medical journal.

[18]  J. Turtle,et al.  Hypoglycemic Action of Fenfluramine in Diabetes Mellitus , 1973, Diabetes.

[19]  L. J. Duncan,et al.  Comparison of continuous and intermittent anorectic therapy in obesity. , 1968, British medical journal.

[20]  B. Clarke,et al.  Comparison of chlorpropamide and metformin treatment on weight and blood-glucose response of uncontrolled obese diabetics. , 1968, Lancet.

[21]  J. Silverstone,et al.  Obesity in diabetes. Some considerations on treatment. , 1966, The American journal of clinical nutrition.

[22]  D. A. Seaton,et al.  Diethylpropion in the Treatment of “Refractory” Obesity , 1961, British medical journal.

[23]  G. Engleson.  Studies in Diabetes Mellitus , 1954, Acta paediatrica. Supplementum.

[24]  L. H. Newburgh.  CONTROL OF THE HYPERGLYCEMIA OF OBESE DIABETICS BY WEIGHT REDUCTION , 1942 .

[25]  L. H. Newburgh,et al.  A NEW INTERPRETATION OF HYPERGLYCEMIA IN OBESE MIDDLEAGED PERSONS , 1939 .

[26]  L. Dublin,et al.  STUDIES IN DIABETES MELLITUS. IV. ETIOLOGY. PART 1 , 1936 .